Simultaneous analysis of millions of individual cells could revolutionise treatments of cancer and cardiovascular, neurological, inflammatory and infectious diseases.
As UK looks about to lose its place in virtual European clinical networks, Cambridge University geneticist says ‘this isn’t some nebulous thing’ - a disease might only affect 50 people in the UK, but the top expert may be in Amsterdam
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.